Immunogen Inc. (IMGN) PT Lowered to $12 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst John Newman lowered the price target on Immunogen Inc. (NASDAQ: IMGN) to $12.00 (from $20.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
